Abstract Summary The National Osteoporosis Guideline Group (NOGG) has revised the UK
guideline for the assessment and management of osteoporosis and the prevention of …

Glucocorticoids are widely used to suppress inflammation or the immune system. High
doses and long-term use of glucocorticoids lead to an important and common iatrogenic …

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …

Glucocorticoid-induced osteoporosis is the most common secondary cause of osteoporosis
and the resulting fractures cause significant morbidity. Following initiation of oral …

It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …

Systemic corticosteroids play an integral role in the management of many inflammatory and
immunologic conditions, but these agents are also associated with serious risks …

Approximately 10 million men and women in the US have osteoporosis, 1 a metabolic bone
disease characterized by low bone density and deterioration of bone architecture that …

Corticosteroid-induced osteoporosis is the most common form of secondary osteoporosis
and the first cause in young people. Bone loss and increased rate of fractures occur early …

Guidelines for clinical practice are aimed to indicate preferred approaches to medical
problems as established by scientifically valid research. Double-blind placebo controlled …

Osteoporosis associated with long-term glucocorticoid therapy remains a common and
serious bone disease. Additionally, in recent years it has become clear that more subtle …